Login to Your Account

Hot Technology - Part 2

Multispecific Antibodies Offer Flexibility in Drug Development

By Peter Winter

Monday, February 25, 2013

As outlined in the first part of this article scanning the rapidly evolving technology landscape of bispecific and multispecific antibodies, interest in them has been renewed big time because various manufacturing, stability and safety issues have been addressed. The field now encompasses a multitude of approaches for creating antibodies against a variety of targets and the number of companies entering this space is surging.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription